RENX Renalytix AI plc

LSE · GB · Healthcare · Health Information Services · renalytix.com

6.000GBP0.00%Mkt Cap: 51.60M $P/E: —4d ago

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs …

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc. Class A Common Stock

$44.25BUSDP/E 44.9

TEM

Tempus AI, Inc. - Class A Common Stock

$13.83BUSD

BTSG

BrightSpring Health Services, Inc. - Common Stock

$11.92BUSDP/E 53.8

HNGE

Hinge Health, Inc. Class A Common Stock

$7.88BUSDP/E 11.9

HQY

HealthEquity, Inc. - Common Stock

$7.45BUSDP/E 32.5

DOCS

Doximity, Inc. Class A Common Stock

$4.98BUSDP/E 31.0

WAY

Waystar Holding Corp. - Common Stock

$4.76BUSDP/E 35.4

HTFL

Heartflow, Inc. - Common Stock

$4.29BUSD

PRVA

Privia Health Group, Inc. - Common Stock

$2.59BUSDP/E 92.3

SDGR

Schrodinger, Inc. - Common Stock

$2.27BUSD

OMCL

Omnicell, Inc. - Common Stock

$1.53BUSDP/E 40.0

CERT

Certara, Inc. - Common Stock

$1.43BUSD

OMDA

Omada Health, Inc. - Common Stock

$1.25BUSDP/E 30.4

GDRX

GoodRx Holdings, Inc. - Class A Common Stock

$1.12BUSDP/E 54.7

TDOC

Teladoc Health, Inc. Common Stock

$1.00BUSD

HSTM

HealthStream, Inc. - Common Stock

$942.97MUSDP/E 42.8

SOPH

SOPHiA GENETICS SA - Ordinary Shares

$686.98MUSD

PHR

Phreesia, Inc. Common Stock

$625.05MUSDP/E 55.9

WEAV

Weave Communications, Inc. Common Stock

$592.92MUSD

RAY-B

RaySearch Laboratories AB Class B

$516.00MUSDP/E 29.1

Key Statistics

Company

Market Cap51.60M USD

Enterprise Value33.12M USD

Revenue (TTM)4.23M USD

Gross Profit1.54M USD

Net Income (TTM)-26.17M USD

Revenue/Share0.0090 GBP

Last Price6.000 GBP

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees46

CountryGB

SectorHealthcare

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.67

PEG—

EV/EBITDA—

EV/Revenue7.82

P/S12.19

P/B-27.03

EPS (TTM)-0.03

EPS (Forward)-0.09

52W Range

1.60044% of range11.50

52W High11.50 GBP

52W Low1.600 GBP

Profitability

Gross Margin40.00%

Oper. Margin-437.50%

EBITDA Margin0.00%

Profit Margin-680.00%

ROE291.43%

ROA-334.43%

Growth

Revenue Growth2.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-22.96M USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-513.04K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-1.19

Current Ratio1.57

Quick Ratio1.39

Book Value/Sh-0.0022 GBP

Cash/Share0.01 GBP

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBP

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.670.46M

Float306.12M

Insiders18.31%

Institutions47.72%

Technical

SMA 504.617 (+30.0%)

SMA 2003.516 (+70.6%)

Beta1.87

S&P 52W Chg14.58%

Avg Vol (30d)1.74M

Avg Vol (10d)1.11M

Technical Indicators

RSI (14)65.8

MACD0.4930

MACD Signal0.5977

MACD Hist.-0.1047

BB Upper7.161 GBP

BB Middle5.875 GBP

BB Lower4.589 GBP

BB Width43.78%

ATR (14)0.4813 GBP

Vol Ratio (20d)0.40x